SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 5, 2008
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
(Exact name of registrant as specified in its charter)
Delaware | 1-11596 | 58-1954497 |
(State or other | (Commission File | (IRS Employer |
jurisdiction of | Number) | Identification No.) |
incorporation) |
8302 Dunwoody Place, Suite 250, Atlanta, Georgia | 30350 |
(Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code (770) 587-9898
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 8 - Other Events
Item 8.01 - Other Events
On June 5, 2008, the Environmental Protection Agency (“EPA”) issued a draft permit to a subsidiary of the Company for the destruction of polychlorinated biphenyl (“PCBs”) in radiological wastes. Subject to a number of conditions being met, including, but not limited to, a public comment period, the Company expects the final permit for the destruction of PCBs in radiological wastes to be issued by the end of 2008.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PERMA-FIX ENVIRONMENTAL SERVICES, INC. | ||||
Dated: | June 6, 2008 | By: | /s/ Dr. Louis Centofanti | |
Chairman of the Board and | ||||
Chief Executive Officer | ||||